Omeros Corporation (OMER)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.27B
Last updated: Nov 17, 2026 at 11:06 AM ET
Omeros Corporation (OMER) Stock Forecast
Analysts expect Omeros (OMER) to earn $0.69 per share in the fiscal year ending Dec 31, 2026, on revenue of $127.50M. Of 3 analysts, 2 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 2.33, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 67% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 2 | 66.7% |
| Hold | 1 | 33.3% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 78.3% and revenue estimates rise 73.6%.
- Fiscal year ending Dec 31, 2026
- $0.69
- EPS consensus, revenue $127.50M
- Fiscal year ending Dec 31, 2027
- $1.23
- EPS consensus, revenue $221.33M
- Next report
- Mar 29, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.69 | $0.50 to $0.88 | 2 | $127.50M | $103.10M to $151.10M | 3 |
| Dec 31, 2027 | $1.23 | $0.24 to $2.22 | 2 | $221.33M | $191.20M to $274.30M | 3 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.07 | -$0.02 to $0.14 | 5 | $52.85M | $33.12M to $75.64M | 5 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 81.6% from $0.38.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.69 | $0.69 | $0.66 | $0.66 | $0.38 | +81.6% |
| Fiscal year ending Dec 31, 2027 | $1.23 | $1.23 | $1.15 | $1.15 | -$0.16 | N/A |
Frequently Asked Questions About OMER
What is the OMER stock forecast?
Consensus analyst estimates put Omeros's EPS at $0.69 for the fiscal year ending Dec 31, 2026, on revenue of $127.50M. The consensus rating from 3 analysts is Buy.
How do analysts rate OMER stock?
Of 3 analysts covering Omeros, 0 rate it Strong Buy, 2 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from OMER next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.69, with estimates from $0.50 to $0.88 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.23, with estimates from $0.24 to $2.22 from 2 analysts.
What revenue do analysts expect from Omeros next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $127.50M, with estimates from $103.10M to $151.10M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $221.33M, with estimates from $191.20M to $274.30M.
How many analysts cover OMER?
3 analysts rate Omeros stock, and 2 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
OMER pages: Overview, Earnings, Forecast, Financials, Competitors